S. SriussadapornS. PloybutrT. PeerapatditMahidol University2018-07-042018-07-041996-02-14British Journal of Clinical Practice. Vol.50, No.1 (1996), 9-13000709472-s2.0-0029666031https://repository.li.mahidol.ac.th/handle/20.500.14594/17760The efficacy of a nocturnal 8mg dexamethasone suppression test (nocturnal DST) was compared with that of the standard high-dose dexamethasone suppression test (standard DST) in identifying the cause of endogenous Gushing's syndrome in 10 proven cases with Gushing's disease, 20 with adrenal tumours, and one with ectopic ACTH syndrome. The nocturnal test compared serum cortisol concentration at 8am before and after administration of a single dose of 8mg dexamethasone at 11pm. Suppression of serum cortisol level to < 50% of the baseline value indicated a diagnosis of Gushing's disease, while a lack of suppression below that limit indicated one of the other two causes of Gushing's syndrome: glucocorticoid-secreting adrenal tumour or ectopic ACTH syndrome. The nocturnal DST had a sensitivity of 90%, a specificity of 100%, an accuracy of 96.8%, a positive predictive value of 100%, and a negative predictive value of 95.5%. These values are comparable to the efficacy of the standard DST in distinguishing Gushing's disease from glucocorticoid-secreting adrenocortical tumour or ectopic ACTH syndrome. Furthermore, this rapid test does not require hospitalisation or urine collection like the standard DST. The nocturnal 8mg dexamethasone suppression test is practical, fairly reliable, and an effective alternative with which to identify the cause of endogenous Gushing's syndrome.Mahidol UniversityMedicineArticleSCOPUS